Background: Ventricular arrhythmias (VA) are a common cause of sudden death after myocardial infarction (MI). Therefore, developing new therapeutic methods for the prevention and treatment of VA is of prime importance. Methods: Human bone marrow derived CD271 + mesenchymal stem cells (MSC) were tested for their antiarrhythmic effect. This was done through the development of a novel mouse model using an immunocompromised Rag2 −/− γc −/− mouse strain subjected to myocardial "infarction-reinfarction". The mice underwent a first ischemia-reperfusion through the left anterior descending (LAD) artery closure for 45 min with a subsequent second permanent LAD ligation after seven days from the first infarct. Results: This mouse model induced various types of VA detected with continuous electrocardiogram (ECG) monitoring via implanted telemetry device. The immediate intramyocardial delivery of CD271 + MSC after the first MI significantly reduced VA induced after the second MI. Conclusions: In addition to the clinical relevance, more closely reflecting patients who suffer from severe ischemic heart disease and related arrhythmias, our new mouse model bearing reinfarction warrants the time required for stem cell engraftment and for the first time enables us to analyze and verify significant antiarrhythmic effects of human CD271 + stem cells in vivo. make them very unlikely to produce hazardous action potentials or contribute to arrhythmias [10, 11] . However, the availability of a realistic small animal model reflecting the situation in patients is of utmost importance. For testing the rhythmological behavior of human cells, Rag2 −/− γc −/− has been selected. These mice (strain C, 129S4-Rag2 tm1.1Flv Il2rg tm1.1Flv /J) have been derived from a V17 embryonic stem cell line (BALB/c × 129 heterozygote) targeted for the Rag2 and Il2rg genes and lack B, T, and natural killer (NK) cells [12] . They have a deletion of the common cytokine receptor γ chain (γc) gene, and thus reduced numbers of peripheral T and B lymphocytes, and absent natural killer cell (NK) activity. A genetic cross with a recombinase activating gene 2 (RAG2) deficient strain produced mice doubly homozygous for the γc and RAG2 null alleles (Rag2 −/− γc −/− ) with a stable phenotype characterized by the absence of all T lymphocyte, B lymphocyte, and NK cell function [13] . This phenotype makes the completely a lymphoid strain useful for studies on human tissue xenotransplantation [14] .
Introduction
Deaths arising from ventricular arrhythmias (VA) after acute cardiac events, in Germany, have increased by 100% over the last twenty years [1] . Therefore, new therapeutic methods for the prevention of VA following myocardial infarction (MI) need to be developed. There are reports that have indicated that transplanting of various stem cell populations post MI can influence the heart rhythm. Some have been defined as pro-arrhythmogenic cells, i.e., skeletal myoblasts, while others have shown antiarrhythmic effects, such as embryonic cardiomyocytes and mesenchymal stem cells (MSC) [2] [3] [4] [5] . Our research group has focused on the role of human bone marrow (BM) derived hematopoiesis such as MSC in regenerative medicine [6] [7] [8] [9] . In previous studies we have shown that it is safe to use CD117 + stem cells for myocardial regeneration, as their electrophysiological properties
Animals
All animal procedures were performed according to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. The federal animal care committee of LALLF Mecklenburg-Vorpommern (Germany) approved the study protocol (approval number LALLF M-V/TSD/7221.3-1-020/14). The Rag2 −/− γc −/− mice (strain C, 129S4-Rag2 tm1.1Flv Il2rg tm1.1Flv /J) were purchased from the Jackson Laboratory (USA).
Ambulatory ECG Monitoring and Ligation of the Left Anterior Descending Artery
For ambulatory electrocardiogram (ECG) monitoring, twelve-to-fourteen-week-old female Rag2 −/− γc −/− mice (n = 22) were implanted with a telemetric device (Data Sciences International, DSI, New Brighton, Minnesota, USA) 7 days before performing the myocardial intervention. The mice were anesthetized with pentobarbital (50 mg/kg, intraperitoneal). An incision was made on the left thorax along the ribs to insert a telemetric transmitter (TA11ETA-F10 Implant; DSI) into a subcutaneous pocket with paired wire electrodes placed over the thorax with leads tunneled to the right upper and left lower thorax. The heart rate, PR interval and QRS complex as the entities of an ECG were recorded using Ponemah Physiology Platform (DSI) until 48 h post infarction. Telemetric ECG signal was qualitatively analyzed, and VA were detected and counted with ECG auto 1.5.11.26 software (EMKA Technologies, Paris, France).
Mice were randomly assigned into three groups: (untreated reinfarction, URI; stem cell treated reinfarction, SRI; and MI control, MIC). First, animals of all three groups underwent thoracotomy, as well as the ligation of the left anterior descending (LAD) artery. After 45 min, each mouse received an intramyocardial application of 20 µL BD Matrigel TM Matrix (BD Biosciences, San Jose, CA, USA) and MACS Buffer in a ratio of 1/2. For stem cell treatment (SRI group) a total of 100,000 CD271 + MSC were injected at 4 sites along the border of the blanched myocardium (25,000 cells per injection point). Subsequently, the node was reopened (here, ischemia-reperfusion) leaving the ligature in the heart looped around the LAD with their ends kept inserted in a soft flexible tube placed subcutaneously ( Figure 1A) .
After an observation period of 7 days, every mouse underwent a second thoracotomy and, subsequently, animals of URI, as well as the SRI group, underwent permanent LAD ligation at the same site and using the suture from the first ligation (here, reinfarction). The rubber tube has facilitated finding of the suture material which was easily exempted from the surrounding tissue. MIC operated mice underwent an identical second surgical procedure without LAD ligation. 
Basic ECG Parameters
To evaluate the antiarrhythmic mechanism of the CD271 + MSC the basic ECG parameters of the mouse groups were measured at different time points. This was performed automatically with the use of ecgAUTO v3.3.0.28 software after manual definition of the start of P wave, the start of Q wave, R wave, end of S wave, and end of T wave. Then, the analysis was done for many subsequent beats at a specific time point. We measured the RR-interval, QRS duration, and QT-interval in milliseconds. The corrected QT-intervals (QTc) were measured using the formula QTc = 
To evaluate the antiarrhythmic mechanism of the CD271 + MSC the basic ECG parameters of the mouse groups were measured at different time points. This was performed automatically with the use of ecgAUTO v3.3.0.28 software after manual definition of the start of P wave, the start of Q wave, R wave, end of S wave, and end of T wave. Then, the analysis was done for many subsequent beats at Cells 2019, 8, 1474 5 of 13 a specific time point. We measured the RR-interval, QRS duration, and QT-interval in milliseconds. The corrected QT-intervals (QTc) were measured using the formula QTc = QT/(RR/100) 1 /2 , as previously described [18] . The basic ECG parameters were measured at the time points (1) 48 h after the first LAD ligation, (2) immediately before, and (3) 48 h after the second intervention.
Definitions of Various Ventricular Arrhythmias
The first temporary occlusion of the LAD resulted in a rapid onset of hyper acute T waves along with ST-segment elevation, as observed in the ECG record. Through reopening of the LAD 45 min post ligation, and subsequent myocardial reperfusion, ST-segment returned back to the isoelectric line and a development of Q waves could be observed. Figure 1B shows the recorded ECG before LAD occlusion, at the time of LAD occlusion, immediately after reopening of the LAD and reperfusion, as well as 12 h after the induction of the MI with clear Q waves and recognizable T waves. Figure 1C shows the onset of the second infarction after permanently ligating the suture already placed at the time of the first ischemia one week earlier. The ECG immediately prior to performing reinfarction through the second LAD ligation shows deep S waves with deeply depressed ST-segment 7 days after the first operation (ischemia-reperfusion). The induction of the second MI with permanent ligation of the LAD led into an immediate ST-segment elevation in the ECG with subsequent development of deep Q waves. Two hours after reinfarction the ECG shows, a still elevated ST-segment reflecting the permanent LAD ligation. At 12 h post the second MI, Q waves developed with still elevated ST-segment with reappearance of T waves.
Both, the first and second infarctions resulted in the development of different types of VA, namely ventricular premature beats (VPB), ventricular bigeminies and trigeminies (BG/TG), ventricular salvos, as well as ventricular tachycardia (VT) ( Figure 1D ).
We have analyzed, named, and defined the observed VA in this mouse model in accordance with a standard that fits the previously established guidelines for labeling and describing each type of VA [19] as follows:
Ventricular premature beats
We have defined VPB, as a ventricular electrical complex which varies in voltage (i.e., height) or duration (i.e., width) from the preceding non-VPB ventricular complex and occurs prematurely in relation to it. This means that VPB are not preceded by a P wave if they appear during the early cardiac cycle or they have shorter PR-intervals than those of non-VPB if they appear later in the cardiac cycle.
Bigeminies and trigeminies
A minimum sequence of VPB, normal sinus beat, and VPB repeated at least three times has been defined as bigeminy. The number of repetitions has been defined as three in our model. Additionally, we have defined a sequence of VPB, two normal sinus beats, and a consecutive VPB with a repetition of three times as trigeminy.
Salvos
The observation of two or three consecutive VPB has been defined as salvo [19] .
Ventricular tachycardia
VT is defined as a sequence of four or more consecutive VPB [19, 20] . This varies between three or more consecutive VPB to ten or more consecutive VPB [21, 22] . A detailed description of the morphological and durational subtypes and classifications of VT has not been performed in these mouse models.
Organ Harvesting
Every mouse underwent euthanization, 48 h after the second intervention by cervical dislocation. Each heart was removed, embedded in O.C.T. TM Compound (Sakura Finetek, Alphen aan den Rijn, Netherlands) and snap frozen in liquid nitrogen. For further histological examination of the infarction area the heart tissue was divided into four horizontal levels from the apex to the base and cut into 5 µm thick slices. 
Human Cells Detection

Infarction Size and Leukocytes Infiltration Area Analysis
Randomly chosen histological heart sections of four horizontal infarct levels were stained with Fast Green FCF (Sigma-Aldrich, Saint Louis, Missouri, USA) and Sirius Red (Chroma Waldeck GmbH & Co. KG, Münster, Germany) assessing tissue localization and distribution of connective fibers. Two contiguous levels of the heart (n = 6 for each group) which represent the major infarction ratio were quantitatively estimated using computer aided image analysis (AxioVision LE Rel.4.5 software, Carl Zeiss AG, Oberkochen, Germany). To evaluate leukocytes infiltration area 48 h after the second ligation, the two contiguous levels of the heart which represent the major infarct ratio were stained with Hematoxylin (Merck, Darmstadt, Germany) and Eosin (Thermo Shandon Ltd., Runcorn, UK) and representative images were taken using computerized planimetry (AxioVision LE Rel.4.5 software).
Statistical Analysis
Statistical analysis was performed using SigmaStat (Version 3.5, Systat Software, San Jose, CA, USA) and IBM SPSS Statistics for Windows (Version 22.0., IBM Corp., Armonk, NY, USA). The comparisons of two experimental groups were performed using Mann-Whitney U test. p values ≤ 0.05 were considered as statistically significant.
Results
Immunophenotypic Analysis of CD271 + Mesenchymal Stem Cells
We isolated CD271 + stem cells according to our established protocol which yields all mesenchymal colony forming progenitors [17, 23] . Again, flow cytometric analysis confirmed a mesenchymal phenotype, reflected by significant overexpression of CD73 and CD105 markers in the isolated CD271 + cell fraction as compared with the entire BM-MNC fraction (9.2% ± 2.8% vs. 0.6% ± 0.2% for CD73 and 8.3% ± 2.8% vs. 0.5% ± 0.2% for CD105, respectively, Figure 2 ). Moreover, only a subfraction of CD271 + cells coexpressed all of the mesenchymal markers while being CD45 − (1.2% ± 0.3% CD271 + CD44 + CD73 + CD105 + of CD271 + cells).
Induced Ventricular Arrhythmias
Aiming to develop a murine in vivo model to study human stem cell transplantation, we found that VA are only detectable in the first day after induction of MI. To study engraftment and any alteration in the development of transplanted human cells in a murine model it is necessary to use an immunodeficient mouse strain. The trial of testing the potential antiarrhythmic effects of CD271 + MSC through catheter-based transjugular intracardial burst stimulation for induction of VA, a described method by Roell et al. [4] , was not promising. We tested six immune compromised mice in which three mice underwent MI and three were healthy animals. All mice of the infarction group and the healthy group developed VA. This observation did not allow for the creation of a proper control group for comparison. Therefore, burst stimulation does not appear to be a suitable approach when using this mouse strain. Consequently, we developed a new mouse model in which we re-induce VA one week after a first ischemia reperfusion by performing a second permanent ligation. This served to simulate the situation in patients where the affected coronary vessel tends to reclose after successful initial recanalization.
In total, one animal (URI group) out of 22 mice died one-hour post induction of the second infarction, due to development of sinus, and, subsequently, third degree heart block. Consequently, this specimen was excluded from the statistical analysis. No other complications were observed after subcutaneous implantation of the telemeter and first LAD ligation, as well as the second LAD ligation. and the healthy group developed VA. This observation did not allow for the creation of a proper control group for comparison. Therefore, burst stimulation does not appear to be a suitable approach when using this mouse strain. Consequently, we developed a new mouse model in which we re-induce VA one week after a first ischemia reperfusion by performing a second permanent ligation. This served to simulate the situation in patients where the affected coronary vessel tends to reclose after successful initial recanalization. In total, one animal (URI group) out of 22 mice died one-hour post induction of the second infarction, due to development of sinus, and, subsequently, third degree heart block. Consequently, this specimen was excluded from the statistical analysis. No other complications were observed after subcutaneous implantation of the telemeter and first LAD ligation, as well as the second LAD ligation. 
Induction of Ventricular Arrhythmias after the Reinfarction
To simplify the study of the mechanisms underlying the developed VA, the ECG analyses were subdivided into an acute phase until 15 minutes and 15 to 45 minutes post intervention, as well as a delayed phase after 12 hours (Table 1) , as previously classified by [24] . There were no significant differences in any of the evolved arrhythmias between the groups after the first infarction. Likewise, quantitatively, there was no observed difference in the frequency of the development of VPB, ventricular salvos, and BG/TG 12 hours after the first myocardial insult ( Figure 3A) .
The quantitative assessment of VPB events within 12 hours following the second LAD ligation (URI) revealed a significant difference as compared with the control group MIC (1105.0 ± 1146.72 vs. 7.5 ± 8.98, respectively, Figure 3B ). This significant difference is also evident in the time frame between 45 minutes and 12 hours after the permanent infarction (URI 1082.2 ± 1127.77 vs. MIC 3.3 ± 2.42, Figure 3C ). There was no significant difference in the occurrence of VPB after the first LAD ligation of both groups (URI 60.1 ± 42.19 vs. MIC 259.0 ± 457.69) for the first 12 hours and at the time point between 45 minutes and 12 hours (URI 54.5 ± 39.85 vs. MIC 246.8 ± 440.84).
Interestingly, while a significant occurrence of VT after performing the second LAD ligation was identified for URI (32.6 ± 52.5), one week after the onset of the first ligation, none of that was observed in the MIC. This occurred during the first 12 hours after the second infarction ( Figure 3B) and also in the time frame between 45 minutes and 12 hours after the second infarction ( Figure 3C ). 
To simplify the study of the mechanisms underlying the developed VA, the ECG analyses were subdivided into an acute phase until 15 min and 15 to 45 min post intervention, as well as a delayed phase after 12 h (Table 1) , as previously classified by [24] . There were no significant differences in any of the evolved arrhythmias between the groups after the first infarction. Likewise, quantitatively, there was no observed difference in the frequency of the development of VPB, ventricular salvos, and BG/TG 12 h after the first myocardial insult ( Figure 3A) .
The quantitative assessment of VPB events within 12 h following the second LAD ligation (URI) revealed a significant difference as compared with the control group MIC (1105.0 ± 1146.72 vs. 7.5 ± 8.98, respectively, Figure 3B ). This significant difference is also evident in the time frame between 45 min and 12 h after the permanent infarction (URI 1082.2 ± 1127.77 vs. MIC 3.3 ± 2.42, Figure 3C ). There was no significant difference in the occurrence of VPB after the first LAD ligation of both groups (URI 60.1 ± 42.19 vs. MIC 259.0 ± 457.69) for the first 12 h and at the time point between 45 min and 12 h (URI 54.5 ± 39.85 vs. MIC 246.8 ± 440.84). Interestingly, while a significant occurrence of VT after performing the second LAD ligation was identified for URI (32.6 ± 52.5), one week after the onset of the first ligation, none of that was observed in the MIC. This occurred during the first 12 h after the second infarction ( Figure 3B) and also in the time frame between 45 min and 12 h after the second infarction ( Figure 3C ). There was no significant difference in terms of the development of VT after the first infarction (URI 1 ± 2.6 vs. MIC 1.6 ± 1.8).
Antiarrhythmic Effects of CD271 + MSC Engraftment
The intramyocardial implantation of human CD271 + MSC did not lead to a significant difference in the number of VA early after the first MI ( Figure 3A) , but showed antiarrhythmic effects by significantly reducing the quantitatively measured VPB which occurred after a reinfarction during the time frame between LAD ligation until 12 h, thereafter (URI 1105.0 ± 1146.72 vs. SRI 178.16 ± 370.12, Figure 3B ). Such significant antiarrhythmic behavior was also reflected in a reduction of the number of VT 45 min after the second LAD ligation until 12 h post reinfarction (URI 32.6 ± 52.51 vs. SRI 0 ± 0, Figure 3C ). Moreover, there was no significant difference in BG/TG and salvos occurrence between the two groups.
In order to further assess the mechanism of antiarrhythmic effect, ECG monitoring was used. Accordingly, we measured the mean QRS duration and the corrected QT-interval ( Figure 3D) . Immediately prior to the second LAD ligation (seven days after the first intervention), the stem cell treated animals had a significantly shorter QRS duration (URI 20.77 ± 1.98 vs. SRI 14.66 ± 0.61 and MIC 19.83 ± 0.54 milliseconds, Figure 3E ). The significant shorter QTc-interval in SRI (URI 64.25 ± 3 vs. SRI 53.54 ± 3.52 and MIC 67.25 ± 4.14 milliseconds, Figure 3F ) could be secondary to the shorter QRS duration as the QRS duration is an integral part of QT duration. There was no statistically significant difference in the mean QRS durations and QTc between URI and MIC immediately prior to the second intervention, as well as between any of the groups 48 h after the first LAD ligation.
After nine days, the engrafted human cells were successfully detected on SRI mouse heart cryosections predominantly in the peri-infarct area by immunofluorescent staining (Figure 3G ). 
Alterations of the Infarct Scar
The first ligation of the LAD and opening of the node after 45 min (ischemia-reperfusion) consistently resulted in a transmural MI with its typical histologic changes including the thinning of the left ventricular free wall (Fast Green) and extensive collagen deposition (Sirius Red) nine days post intervention ( Figure 4A ). After stem cell injection we observed no significant reduction in infarct scar formation (SRI, 14.78% ± 5.85%) in contrast to untreated infarction (URI 17.28% ± 5.10% URI), as well as to control group (MIC, 19.42% ± 3.66%, Figure 4C ).
The first ligation of the LAD followed by a permanent second LAD ligation resulted in leukocyte infiltration within the infarction area as depicted in the images of Hematoxylin and Eosin stained slices from hearts 48 h post infarction ( Figure 4B ). This cellular intervention consequently led to a significant enlargement of the myocardial scar area in URI (38.54% ± 14.28%), as well as SRI (29.36% ± 8.63%) in comparison to MIC (20.1% ± 4.04%, Figure 4C ). 
The first ligation of the LAD and opening of the node after 45 minutes (ischemia-reperfusion) consistently resulted in a transmural MI with its typical histologic changes including the thinning of the left ventricular free wall (Fast Green) and extensive collagen deposition (Sirius Red) nine days post intervention ( Figure 4A ). After stem cell injection we observed no significant reduction in infarct scar formation (SRI, 14.78% ± 5.85%) in contrast to untreated infarction (URI 17.28% ± 5.10% URI), as well as to control group (MIC, 19.42% ± 3.66%, Figure 4C ).
The first ligation of the LAD followed by a permanent second LAD ligation resulted in leukocyte infiltration within the infarction area as depicted in the images of Hematoxylin and Eosin stained slices from hearts 48 hours post infarction ( Figure 4B ). This cellular intervention consequently led to a significant enlargement of the myocardial scar area in URI (38.54% ± 14.28%), as well as SRI (29.36% ± 8.63%) in comparison to MIC (20.1% ± 4.04%, Figure 4C ). 
Discussion
The purpose of this study was to develop a mouse model to reproduce VA that typically occurs in patients several days after an initial MI. To study engraftment and development of human cells in a murine model it was necessary to use an immunodeficient mouse strain. During development of an in vivo model of immunodeficient mice for the study of human stem cell transplantation, we found that VA are mostly seen only on the first day after induced MI. Our results supported the hypothesis, that a therapeutic stem cell treatment could have no such antiarrhythmic effect early after their transplantation, as previously shown for other cells [4] . For testing potential antiarrhythmic effects of intramyocardially transplanted cells, Roell et al. induced VA in vivo through transjugular venous catheter mediated burst stimulation of the myocardium after inducing MI [4] . However, this conventional approach could not be utilized in immunodeficient mice, because 
The purpose of this study was to develop a mouse model to reproduce VA that typically occurs in patients several days after an initial MI. To study engraftment and development of human cells in a murine model it was necessary to use an immunodeficient mouse strain. During development of an in vivo model of immunodeficient mice for the study of human stem cell transplantation, we found that VA are mostly seen only on the first day after induced MI. Our results supported the hypothesis, that a therapeutic stem cell treatment could have no such antiarrhythmic effect early after their transplantation, as previously shown for other cells [4] . For testing potential antiarrhythmic effects of intramyocardially transplanted cells, Roell et al. induced VA in vivo through transjugular venous catheter mediated burst stimulation of the myocardium after inducing MI [4] . However, this conventional approach could not be utilized in immunodeficient mice, because of the sensitivity of these animals as we observed. For this reason, there was an urgent need for the development of a new mouse model that used immunodeficient mice for in vivo study of antiarrhythmic effects exerted by various human-derived stem cells. On the basis of this, we aimed to develop a new mouse model with re-induced VA by performing a permanent second LAD ligation seven days after re-perfused of the first MI. Indeed, performing the second ligation, one week after the first infarction in Rag2 −/− γc −/− mice, reproduced cardiac arrhythmias. Other previously described small animal models in this field have utilized immune competent mice or rats subjected to higher stress after performing recurrent transient ischemia following an operatively instrumented mice with the capability of subsequent recurrent transient closure of the LAD [25, 26] .
The previously described development of VPB in the control group after anesthesia and surgery without performing LAD ligation [27] has also been seen in our mouse model in the time period between 15 and 45 min after re-thoracotomy (without the second LAD ligation) in MIC group. These developed VPB were statistically not significant as compared with the SRI and URI groups.
Our stem cell therapy resulted in shorter QRS duration, shorter QTc-intervals, and decreased occurrence of VT in the early period after the second MI. The observed shortening of QRS indicates the ability of MSC to improve cardiac electric conduction, which is in line with findings from Boink et al. who showed shortened QRS duration in a canine model of MI after MSC transplantation. [28] . However, antiarrhythmic behaviors of human MSC have also been shown in a clinical trial after their intravenous injection following a re-perfused MI [29] . The positive effect may be due to the possible coupling of the MSC with cardiomyocytes through connexin 43 (Cx43) bridges, as it has been found in an in vitro study by our research group [17] . This may be especially relevant as Cx43 plays a major role in post ischemia and post infarction cardiac arrhythmias in the time period between 45 min and 12 h after MI in different animal models [24] .
As there is a close relationship between the infarct size and the incidence of VA [30] , the significant reduction of the developed VA in the SRI group could not be attributed to the infarct size because there was no significant difference in the infarction area between the SRI and the URI group, early after the second infarction. The Hematoxylin and Eosin staining of the heart sections 48 h after the second intervention (second LAD ligation in SRI and URI groups, re-thoracotomy in MIC group) shows no infarct area expansion and new inflammatory cell infiltration in the MIC group. This indicates that the stained inflammatory cells in SRI and URI groups cannot be remaining cells of the initial MI and their infiltration is the early consequence of the second infarction. Additionally, the lack of intensive leukocyte infiltration in the MIC group after re-thoracotomy (no second LAD ligation) seen with Hematoxylin and Eosin staining of the heart sections nine days after the first operation (LAD ligation) in our mouse strain supports the finding of Yang et al. [31] . The described initial neutrophil infiltration in the infarct border one to two days after LAD ligation in immunocompetent C57BL/6J mice used by Yang and associates has been clearly seen in our SRI and URI groups 48 h after the second infarction. However, the described later lymphocytic infiltration, seven to 14 days after myocardial injury could not be noticeable in our complete alymphoid mouse strain, Rag2 −/− γc −/− nine days after induced MI.
In this study, we introduce our novel mouse model for testing arrhythmias in the Rag2 −/− γc −/− mouse. Importantly, CD271 + MSC transplanted into the infarcted area were retained and did not bear any proarrhythmic properties but rather antiarrhythmic effects. We have successfully utilized the model to test potential antiarrhythmic effects of human BM derived CD271 + stem cells in vivo and showed their safety and efficacy. Therefore, we conclude, that human BM derived MSC, i.e., CD271 + are suitable cell types to prevent arrhythmias after MI. This finding supports the previous observations on the safety of intramyocardial transplantation of BM derived stem cells and can be further evaluated for future clinical implication of cell transplantation in the field of electrophysiology [32] . Overall, our novel mouse model offers a new option for testing potential antiarrhythmic effects of cell transplantation therapies with high clinical relevance.
